Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 287,498
  • Shares Outstanding, K 58,198
  • Annual Sales, $ 192,640 K
  • Annual Income, $ 2,510 K
  • 60-Month Beta 0.77
  • Price/Sales 1.54
  • Price/Cash Flow N/A
  • Price/Book 0.55
Trade VNDA with:

Options Overview Details

View History
  • Implied Volatility 79.40% ( +2.44%)
  • Historical Volatility 27.32%
  • IV Percentile 80%
  • IV Rank 52.31%
  • IV High 132.67% on 01/02/24
  • IV Low 20.96% on 10/04/23
  • Put/Call Vol Ratio 0.70
  • Today's Volume 1,485
  • Volume Avg (30-Day) 364
  • Put/Call OI Ratio 0.49
  • Today's Open Interest 15,094
  • Open Int (30-Day) 12,541

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.18
  • Number of Estimates 1
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year 0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.85 +2.06%
on 09/12/24
5.53 -10.41%
on 08/26/24
-0.25 (-4.81%)
since 08/16/24
3-Month
4.85 +2.06%
on 09/12/24
6.36 -22.23%
on 07/22/24
-1.39 (-21.92%)
since 06/18/24
52-Week
3.30 +50.23%
on 11/10/23
6.75 -26.67%
on 06/13/24
+0.49 (+10.99%)
since 09/18/23

Most Recent Stories

More News
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment

New research suggests that powerful magnets could effectively treat bipolar disorder. This therapy, which is known as accelerated intermittent theta burst stimulation (iTBS), uses magnetic waves targeted...

ALZN : 1.7300 (+2.98%)
VNDA : 4.95 (+0.20%)
ITCI : 74.70 (-0.55%)
TEVA : 17.88 (+0.17%)
ABBV : 192.94 (-0.26%)
Vanda: Q2 Earnings Snapshot

Vanda: Q2 Earnings Snapshot

VNDA : 4.95 (+0.20%)
Accenture, KB Home rise; Snap, Jabil fall, Thursday, 6/20/2024

Stocks that traded heavily or had substantial price changes on Thursday: Accenture, KB Home rise; Snap, Jabil fall

CG : 42.32 (+0.79%)
CMC : 51.89 (+0.82%)
VNDA : 4.95 (+0.20%)
DFS : 136.11 (-1.07%)
SNAP : 9.67 (+2.65%)
KBH : 86.62 (-0.15%)
ACN : 336.18 (-0.26%)
Vanda: Q1 Earnings Snapshot

Vanda: Q1 Earnings Snapshot

VNDA : 4.95 (+0.20%)
Why Vanda Pharmaceuticals Stock Is Skyrocketing Today

Future Pak wants Vanda, but Vanda doesn't want Future Pak.

VNDA : 4.95 (+0.20%)
Vanda: Q4 Earnings Snapshot

Vanda: Q4 Earnings Snapshot

VNDA : 4.95 (+0.20%)
Vanda Pharmaceuticals Intends to Petition the U.S. Supreme Court in its HETLIOZ® ANDA Litigation

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced its intention to file a petition for a writ of certiorari in its HETLIOZ®...

VNDA : 4.95 (+0.20%)
Vanda Pharmaceuticals Announces Participation in the Jefferies Inaugural Biotech CNS/Neuro Summit

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Jefferies Inaugural Biotech...

VNDA : 4.95 (+0.20%)
Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the H.C. Wainwright Global Investment...

VNDA : 4.95 (+0.20%)
Why Shares of Vanda Pharmaceuticals Are Dropping on Tuesday

The pharmaceutical company's stock hit another 52-week low.

VNDA : 4.95 (+0.20%)

Business Summary

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics...

See More

Key Turning Points

3rd Resistance Point 5.14
2nd Resistance Point 5.08
1st Resistance Point 5.01
Last Price 4.95
1st Support Level 4.88
2nd Support Level 4.82
3rd Support Level 4.75

See More

52-Week High 6.75
Fibonacci 61.8% 5.43
Fibonacci 50% 5.02
Last Price 4.95
Fibonacci 38.2% 4.61
52-Week Low 3.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar